CAMBRIDGE, Mass.--(OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Stifel Nicolaus 2012 Healthcare Conference at Four Seasons Hotel Boston on Thursday, September 6, 2012 at 9:10 a.m.)--
OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility. The Company’s patented technology is based on the discovery of egg precursor cells (EggPCs), which are found in the ovaries. By applying proprietary technology to identify and purify EggPCs, OvaScience’s first product candidate, AUGMENTSM, aims to improve egg quality and address the high failure rates of in vitro fertilization (IVF). OvaScience’s team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.